FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearance
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
US FDA misses deadline for decision on Novavax's COVID-19 vaccine
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...
Doctor with wish list for more vaccine scrutiny named assistant to new FDA chief, sources say
Tracy Beth Hoeg, a sports medicine physician and epidemiologist who opposed key U.S. health policies during the COVID-19 ...
FDA Delays Final Approval of Novavax COVID Vaccine
The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...
Fierce Pharma2d
Amid FDA tumult, agency misses decision deadline on Novavax's COVID shot
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
FDA planning for fewer food and drug inspections due to layoffs, officials say
Around 170 staff were cut from the FDA's Office of Inspections and Investigations this week as part of wider cuts at U.S.
FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine (UPDATED)
Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request more data beyond the April 1 deadline.
FDA Misses Deadline for Covid-19 Vaccine Decision
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
CNN3d
FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearance
“We are confident our well-tolerated vaccine represents an important alternative to mRNA Covid-19 vaccines for the US,” Novavax said. The FDA’s press office was put on administrative leave ...
FDA misses approval deadline for Novavax’s COVID-19 vaccine
The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...